marketcaparena
Search

    BTSG

    BrightSpring Health Services, Inc.

    Company overview

    Market capitalization
    —
    Employees
    23,500
    Latest publication
    2026-09-29
    About BrightSpring Health Services, Inc.

    BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ4 20232023-12-31 · USDQ1 20232023-03-31 · USDQ4 20222022-12-31 · USDQ3 20222022-09-30 · USDQ2 20222022-06-30 · USD
    Total Revenue3,873,140,000USD3,052,801,000USD2,906,823,000USD2,374,544,000USD2,028,378,000USD1,970,636,000USD1,981,415,000USD1,884,254,500USD
    Gross Profit492,746,000USD421,899,000USD408,112,000USD368,715,000USD334,713,000USD337,645,000USD335,746,000USD340,426,500USD
    Selling General Administrative362,355,000USD342,846,000USD351,272,000USD300,453,000USD283,158,000USD288,623,000USD——
    Total Operating Expenses362,355,000USD342,846,000USD351,272,000USD300,453,000USD283,158,000USD314,079,000USD299,598,000USD276,368,500USD
    Operating Income130,391,000USD79,053,000USD56,840,000USD68,262,000USD51,555,000USD23,566,000USD36,148,000USD64,058,000USD
    Total Other Income Expense Net-36,879,000USD-54,866,000USD-56,061,000USD-83,054,000USD-78,177,000USD-75,719,000USD-63,368,000USD-47,248,500USD
    Interest Expense36,879,000USD54,866,000USD56,061,000USD83,054,000USD78,177,000USD75,719,000USD63,368,000USD—
    Income Before Tax93,512,000USD24,187,000USD779,000USD-14,792,000USD-26,622,000USD-52,153,000USD-27,220,000USD16,809,500USD
    Income Tax Expense6,908,000USD8,783,000USD9,760,000USD-7,591,000USD-4,346,000USD4,530,000USD-4,241,000USD4,088,000USD
    Discontinued Operations-2,395,000USD———————
    Net Income84,209,000USD15,999,000USD-8,230,000USD-6,537,000USD-21,382,000USD-56,158,000USD-22,691,000USD12,471,000USD
    Minority Interest-81,000USD595,000USD751,000USD664,000USD894,000USD525,000USD——
    Net Income Applicable To Common Shares84,290,000USD———————
    Cost Of Revenue3,108,992,000USD2,630,902,000USD2,498,711,000USD2,005,829,000USD1,693,665,000USD1,632,991,000USD1,645,669,000USD1,543,828,000USD
    Net Interest Income—-54,866,000USD-56,061,000USD-83,054,000USD-78,177,000USD-75,719,000USD——
    Tax Provision—8,783,000USD9,760,000USD-7,591,000USD-4,346,000USD4,530,000USD——
    Net Income From Continuing Ops—15,404,000USD-8,981,000USD-7,201,000USD-22,276,000USD-56,683,000USD——
    Ebit—79,053,000USD56,840,000USD68,262,000USD51,555,000USD23,566,000USD36,148,000USD65,507,999USD
    Ebitda—133,934,000USD107,448,000USD119,274,000USD101,900,000USD76,877,000USD87,186,000USD115,318,500USD
    Depreciation And Amortization—54,881,000USD50,608,000USD51,012,000USD50,345,000USD53,311,000USD51,038,000USD49,810,501USD
    Reconciled Depreciation—54,881,000USD50,608,000USD51,012,000USD50,345,000USD53,311,000USD——
    Unclassified Operating Expenses—————25,456,000USD299,598,000USD276,368,500USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20222022-12-31 · USDFY 20202020-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue7,720,560,000USD5,580,372,000USD2,536,053,000USD
    Cost Of Revenue6,366,316,000USD4,531,634,000USD2,160,144,000USD
    Gross Profit1,354,244,000USD1,048,738,000USD375,909,000USD
    Selling General Administrative1,125,558,000USD883,547,000USD—
    Unclassified Operating Expenses40,856,000USD—301,060,000USD
    Total Operating Expenses1,166,414,000USD883,547,000USD301,060,000USD
    Operating Income187,830,000USD165,191,000USD74,849,000USD
    Interest Expense233,584,000USD138,953,000USD74,613,000USD
    Net Interest Income-233,584,000USD-138,953,000USD—
    Income Before Tax-45,754,000USD26,238,000USD-10,832,000USD
    Income Tax Expense8,465,000USD5,087,000USD-3,211,000USD
    Tax Provision8,465,000USD5,087,000USD—
    Net Income-53,907,000USD20,810,000USD-7,621,000USD
    Net Income From Continuing Ops-54,219,000USD21,151,000USD—
    Ebit187,830,000USD165,191,000USD74,849,000USD
    Ebitda391,800,000USD346,693,000USD156,018,000USD
    Depreciation And Amortization203,970,000USD181,502,000USD81,169,000USD
    Reconciled Depreciation203,970,000USD181,502,000USD—
    Total Other Income Expense Net-233,584,000USD-138,953,000USD-85,681,000USD
    Minority Interest312,000USD-341,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets5,985,717,000USD6,213,314,000USD6,413,311,000USD6,049,497,000USD5,943,597,000USD5,846,945,000USD5,926,140,000USD5,785,967,000USD
    Cash And Equivalents550,381,000USD———————
    Long Term Investments7,544,000USD8,206,000USD8,202,000USD5,821,000USD970,000USD650,000USD670,000USD675,000USD
    Total Current Assets2,469,973,000USD2,689,303,000USD2,894,050,000USD2,780,276,000USD2,647,959,000USD2,528,448,000USD1,893,054,000USD1,709,585,000USD
    Other Current Assets205,163,000USD28,988,000USD918,295,000USD900,347,000USD882,150,000USD875,494,000USD42,152,000USD43,874,000USD
    Other Non Current Assets85,234,000USD———————
    Total Liabilities3,927,515,000USD———————
    Total Current Liabilities1,555,633,000USD1,548,413,000USD1,849,034,000USD1,549,970,000USD1,505,365,000USD1,457,617,000USD1,428,333,000USD1,263,922,000USD
    Other Current Liabilities371,701,000USD———————
    Other Non Current Liabilities1,985,000USD———————
    Total Stockholder Equity2,048,717,000USD1,979,318,000USD1,875,065,000USD1,818,563,000USD1,742,890,000USD1,687,369,000USD1,647,855,000USD1,614,771,000USD
    Total Equity Including Noncontrolling Interest2,058,202,000USD———————
    Short Long Term Debt82,890,000USD52,960,000USD52,340,000USD51,870,000USD50,836,000USD48,725,000USD48,725,000USD48,853,000USD
    Long Term Debt2,149,315,000USD2,444,871,000USD2,455,204,000USD2,465,334,000USD2,477,917,000USD2,489,339,000USD2,561,858,000USD2,608,537,000USD
    Deferred Revenue13,083,000USD———————
    Net Receivables1,139,420,000USD1,211,352,000USD1,072,205,000USD1,100,390,000USD1,070,274,000USD1,066,980,000USD1,149,081,000USD1,151,419,000USD
    Inventory575,009,000USD560,166,000USD815,180,000USD639,195,000USD625,465,000USD533,637,000USD640,568,000USD478,319,000USD
    Property Plant Equipment Net380,842,000USD375,218,000USD376,321,000USD335,083,000USD341,677,000USD339,599,000USD500,034,000USD507,686,000USD
    Goodwill2,535,244,000USD———————
    Intangible Assets514,424,000USD536,884,000USD557,555,000USD521,610,000USD544,337,000USD568,284,000USD811,482,000USD842,479,000USD
    Accounts Payable1,090,915,000USD1,091,434,000USD1,217,946,000USD954,497,000USD965,302,000USD868,080,000USD941,292,000USD783,838,000USD
    Short Term Debt44,663,000USD105,088,000USD102,070,000USD94,814,000USD93,200,000USD90,699,000USD130,503,000USD130,983,000USD
    Common Stock1,975,000USD1,932,000USD1,921,000USD1,807,000USD1,771,000USD1,752,000USD1,742,000USD1,741,000USD
    Retained Earnings38,434,000USD14,135,000USD-74,647,000USD-108,569,000USD-164,405,000USD-192,613,000USD-222,155,000USD-234,380,000USD
    Accumulated Other Comprehensive Income4,185,000USD-1,265,000USD-6,691,000USD-6,291,000USD-4,330,000USD-1,869,000USD1,418,000USD-705,000USD
    Total Liab—4,223,421,000USD4,526,945,000USD4,228,479,000USD4,198,174,000USD4,156,378,000USD4,274,555,000USD4,166,870,000USD
    Other Current Liab—342,715,000USD519,979,000USD492,357,000USD436,365,000USD488,557,000USD335,212,000USD319,528,000USD
    Capital Stock—1,932,000USD1,921,000USD1,807,000USD1,771,000USD1,752,000USD1,742,000USD1,741,000USD
    Good Will—2,533,555,000USD2,545,673,000USD2,370,566,000USD2,370,134,000USD2,370,024,000USD2,671,524,000USD2,672,791,000USD
    Cash—888,797,000USD88,370,000USD140,344,000USD70,070,000USD52,337,000USD61,253,000USD35,973,000USD
    Cash And Short Term Investments—888,797,000USD88,370,000USD140,344,000USD70,070,000USD52,337,000USD61,253,000USD35,973,000USD
    Current Deferred Revenue—9,176,000USD9,039,000USD8,302,000USD8,232,000USD8,730,000USD11,001,000USD20,091,000USD
    Net Debt—1,810,907,000USD2,618,868,000USD2,558,978,000USD2,641,832,000USD2,664,538,000USD2,843,713,000USD2,924,456,000USD
    Short Long Term Debt Total—2,699,704,000USD2,707,238,000USD2,699,322,000USD2,711,902,000USD2,716,875,000USD2,904,966,000USD2,960,429,000USD
    Property Plant Equipment Gross—796,547,000USD781,199,000USD723,004,000USD713,913,000USD695,222,000USD950,343,000USD934,170,000USD
    Common Stock Shares Outstanding—221,321,000shares218,417,000shares217,982,000shares216,336,000shares214,927,000shares213,160,000shares198,491,000shares
    Non Current Assets Total—3,524,011,000USD3,519,261,000USD3,269,221,000USD3,295,638,000USD3,318,497,000USD4,033,086,000USD4,076,382,000USD
    Non Current Liabilities Total—2,675,008,000USD2,677,911,000USD2,678,509,000USD2,692,809,000USD2,698,761,000USD2,846,222,000USD2,902,948,000USD
    Non Current Liabilities Other—1,599,000USD1,457,000USD3,009,000USD11,623,000USD10,667,000USD11,426,000USD12,860,000USD
    Non Currrent Assets Other—60,286,000USD31,510,000USD36,141,000USD35,192,000USD37,629,000USD43,801,000USD46,073,000USD
    Net Working Capital—1,140,890,000USD1,045,016,000USD1,230,306,000USD1,142,594,000USD1,070,831,000USD464,721,000USD445,663,000USD
    Unclassified Current Liabilities—-52,960,000USD-52,340,000USD-51,870,000USD-48,570,000USD-47,174,000USD-38,400,000USD-39,371,000USD
    Unclassified Non Current Liabilities—228,538,000USD221,250,000USD210,166,000USD203,269,000USD198,755,000USD272,938,000USD281,551,000USD
    Unclassified Equity—1,962,584,000USD1,952,561,000USD1,929,809,000USD1,908,083,000USD1,878,347,000USD1,865,108,000USD1,846,374,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets6,413,311,000USD5,926,140,000USD5,532,721,000USD5,441,138,000USD5,513,140,000USD4,541,073,000USD3,817,337,000USD—
    Intangible Assets557,555,000USD811,482,000USD881,476,000USD975,862,000USD1,111,551,000USD1,095,898,000USD1,066,277,000USD—
    Other Current Assets918,295,000USD42,152,000USD30,015,000USD31,761,000USD29,664,000USD27,479,000USD31,632,000USD—
    Total Liab4,526,945,000USD4,274,555,000USD4,920,172,000USD4,657,056,000USD4,712,677,000USD3,805,698,000USD3,107,108,000USD—
    Total Stockholder Equity1,875,065,000USD1,647,855,000USD584,740,000USD754,776,000USD774,817,000USD704,984,000USD656,873,000USD—
    Other Current Liab519,979,000USD335,212,000USD452,210,000USD260,276,000USD340,672,000USD265,458,000USD268,246,000USD—
    Common Stock1,921,000USD1,742,000USD1,179,000USD1,179,000USD1,178,000USD745,175,000USD745,878,000USD—
    Capital Stock1,921,000USD1,742,000USD1,179,000USD1,179,000USD1,178,000USD745,175,000USD——
    Retained Earnings-74,647,000USD-222,155,000USD-200,319,000USD-45,716,000USD971,000USD-51,752,000USD-94,284,000USD—
    Good Will2,545,673,000USD2,671,524,000USD2,608,412,000USD2,576,081,000USD2,657,893,000USD1,669,390,000USD1,410,894,000USD—
    Cash88,370,000USD61,253,000USD13,071,000USD13,628,000USD46,735,000USD262,005,000USD18,295,000USD—
    Cash And Short Term Investments88,370,000USD61,253,000USD13,071,000USD13,628,000USD46,735,000USD262,005,000USD18,295,000USD—
    Total Current Assets2,894,050,000USD1,893,054,000USD1,456,641,000USD1,344,256,000USD1,180,614,000USD1,290,382,000USD870,683,000USD—
    Total Current Liabilities1,849,034,000USD1,428,333,000USD1,248,437,000USD932,508,000USD892,161,000USD742,791,000USD621,970,000USD—
    Current Deferred Revenue9,039,000USD11,001,000USD30,848,000USD29,043,000USD10,488,000USD22,758,000USD3,311,000USD—
    Net Debt2,618,868,000USD2,843,713,000USD3,657,520,000USD3,663,441,000USD3,723,805,000USD2,712,293,000USD2,425,202,000USD—
    Short Term Debt102,070,000USD130,503,000USD114,467,000USD107,855,000USD125,219,000USD91,006,000USD89,497,000USD—
    Short Long Term Debt52,340,000USD48,725,000USD32,273,000USD30,407,000USD40,538,000USD22,495,000USD——
    Short Long Term Debt Total2,707,238,000USD2,904,966,000USD3,670,591,000USD3,677,069,000USD3,770,540,000USD2,974,298,000USD2,443,497,000USD—
    Long Term Debt2,455,204,000USD2,561,858,000USD3,331,941,000USD3,364,302,000USD3,393,235,000USD2,671,345,000USD——
    Long Term Investments8,202,000USD670,000USD720,000USD736,000USD2,659,000USD2,476,000USD——
    Net Receivables1,072,205,000USD1,149,081,000USD1,010,779,000USD868,350,000USD804,997,000USD700,839,000USD622,282,000USD—
    Inventory815,180,000USD640,568,000USD402,776,000USD430,517,000USD299,218,000USD300,059,000USD198,474,000USD—
    Accounts Payable1,217,946,000USD941,292,000USD641,607,000USD526,916,000USD408,109,000USD355,754,000USD252,755,000USD—
    Property Plant Equipment Net376,321,000USD500,034,000USD513,354,000USD475,275,000USD524,642,000USD450,708,000USD432,552,000USD—
    Property Plant Equipment Gross781,199,000USD950,343,000USD881,443,000USD771,314,000USD749,421,000USD612,127,000USD——
    Accumulated Other Comprehensive Income-6,691,000USD1,418,000USD12,544,000USD21,192,000USD217,000USD185,000USD132,000USD—
    Common Stock Shares Outstanding219,774,000shares192,997,000shares171,190,389shares171,190,389shares171,190,389shares171,190,389shares171,190,389shares171,190,389shares
    Non Current Assets Total3,519,261,000USD4,033,086,000USD4,076,080,000USD4,096,882,000USD4,332,526,000USD3,250,691,000USD2,946,654,000USD—
    Non Current Liabilities Total2,677,911,000USD2,846,222,000USD3,671,735,000USD3,724,548,000USD3,820,516,000USD3,062,907,000USD2,485,138,000USD—
    Non Current Liabilities Other1,457,000USD11,426,000USD54,894,000USD37,329,000USD7,275,000USD17,690,000USD——
    Non Currrent Assets Other31,510,000USD43,801,000USD72,118,000USD68,928,000USD35,781,000USD32,219,000USD34,562,000USD—
    Net Working Capital1,045,016,000USD464,721,000USD208,204,000USD411,748,000USD288,453,000USD547,591,000USD——
    Unclassified Current Liabilities-52,340,000USD-38,400,000USD-22,968,000USD-21,989,000USD-32,865,000USD-14,680,000USD8,161,000USD—
    Unclassified Non Current Liabilities221,250,000USD272,938,000USD284,900,000USD322,917,000USD420,006,000USD373,872,000USD2,485,138,000USD—
    Unclassified Equity1,952,561,000USD1,865,108,000USD770,157,000USD776,942,000USD771,273,000USD-733,799,000USD——
    Other Assets———1USD—1USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation80,517,000USD
    Stock Based Compensation23,169,000USD
    Other Non Cash Items-1,014,000USD
    Change To Account Receivables-152,577,000USD
    Change To Inventory239,989,000USD
    Change To Liabilities27,951,000USD
    Change In Working Capital1,280,000USD
    Operating Cash Flow166,859,000USD
    Capital Expenditures-50,576,000USD
    Other Investing Activities-43,269,000USD
    Unclassified Investing Cash Flow813,040,000USD
    Investing Cash Flow719,195,000USD
    Net Debt Issuance-326,313,000USD
    Common Stock Issuance32,415,000USD
    Net Common Stock Issuance-126,607,000USD
    Unclassified Financing Cash Flow-3,645,000USD
    Financing Cash Flow-424,150,000USD
    Change In Cash461,904,000USD
    End Cash Flow550,381,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income74,440,000USD77,320,000USD55,241,000USD27,542,000USD29,010,000USD15,404,000USD-8,981,000USD19,441,000USD
    Depreciation39,094,000USD39,524,000USD40,753,000USD41,839,000USD42,161,000USD54,881,000USD50,608,000USD50,071,000USD
    Stock Based Compensation3,676,000USD14,366,000USD17,250,000USD22,802,000USD15,681,000USD13,980,000USD15,210,000USD15,136,000USD
    Other Non Cash Items-15,939,000USD14,519,000USD5,400,000USD34,629,000USD15,833,000USD18,761,000USD14,519,000USD7,973,000USD
    Change To Account Receivables-114,125,000USD31,402,000USD-49,933,000USD-33,307,000USD-79,449,000USD-15,044,000USD-51,474,000USD3,054,000USD
    Change To Inventory254,833,000USD-175,627,000USD-13,752,000USD-91,827,000USD103,300,000USD-162,249,000USD-103,985,000USD-765,000USD
    Change In Working Capital28,865,000USD89,254,000USD-25,082,000USD-77,597,000USD-5,118,000USD-14,281,000USD-65,589,000USD-90,318,000USD
    Total Cash From Operating Activities122,943,000USD231,559,000USD107,936,000USD49,076,000USD101,598,000USD90,612,000USD27,246,000USD-15,225,000USD
    Capital Expenditures-21,544,000USD-37,665,000USD-15,762,000USD-24,425,000USD-17,632,000USD-15,311,000USD-20,043,000USD-23,743,000USD
    Free Cash Flow101,399,000USD193,894,000USD92,174,000USD24,651,000USD83,966,000USD75,301,000USD7,203,000USD-38,968,000USD
    Total Cashflows From Investing Activities747,393,000USD-233,884,000USD-23,761,000USD-23,243,000USD-24,191,000USD-15,780,000USD-35,827,000USD-57,692,000USD
    Net Borrowings-16,400,000USD-15,754,000USD-17,655,000USD-15,211,000USD-78,500,000USD-47,854,000USD23,997,000USD—
    Total Cash From Financing Activities-70,016,000USD-50,498,000USD-13,107,000USD-8,243,000USD-86,018,000USD-49,552,000USD19,527,000USD39,907,000USD
    Sale Purchase Of Stock-60,000,000USD-43,173,000USD0USD-1,749,000USD-2,763,000USD650,000USD-954,000USD-325,000USD
    Change In Cash800,320,000USD-52,823,000USD71,068,000USD17,590,000USD-8,611,000USD25,280,000USD10,946,000USD-33,010,000USD
    Begin Period Cash Flow88,477,000USD141,300,000USD70,232,000USD52,642,000USD61,253,000USD35,973,000USD25,027,000USD58,037,000USD
    End Period Cash Flow888,797,000USD88,477,000USD141,300,000USD70,232,000USD52,642,000USD61,253,000USD35,973,000USD25,027,000USD
    Other Cashflows From Investing Activities811,140,000USD37,000USD-6,445,000USD1,182,000USD195,000USD-427,000USD360,000USD268,000USD
    Other Cashflows From Financing Activities-5,708,000USD-2,171,000USD4,548,000USD6,968,000USD-7,518,000USD-1,698,000USD-4,470,000USD-1,396,000USD
    Unclassified Operating Cash Flow-7,193,000USD-3,424,000USD14,374,000USD—4,031,000USD1,867,000USD21,479,000USD-17,528,000USD
    Unclassified Investing Cash Flow-42,203,000USD-196,256,000USD22,207,000USD23,243,000USD17,437,000USD15,738,000USD19,683,000USD23,475,000USD
    Unclassified Financing Cash Flow12,092,000USD10,600,000USD—1,749,000USD2,763,000USD—565,250,000USD41,628,000USD
    Issuance Of Capital Stock—0USD0USD0USD0USD0USD0USD0USD
    Investments——-23,761,000USD-23,243,000USD-24,191,000USD-15,780,000USD-35,827,000USD-57,692,000USD
    Dividends Paid——————-564,296,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20222022-12-31 · USDFY 20202020-12-31 · USDFY 20182018-12-31 · USD
    Net Income189,113,000USD-54,219,000USD21,151,000USD-7,621,000USD
    Depreciation164,277,000USD203,970,000USD181,502,000USD81,169,000USD
    Stock Based Compensation70,099,000USD3,547,000USD6,268,000USD1,438,000USD
    Other Non Cash Items70,381,000USD94,476,000USD27,203,000USD16,610,000USD
    Change To Account Receivables-131,287,000USD-150,466,000USD-58,915,000USD-31,408,000USD
    Change To Inventory-177,906,000USD-131,833,000USD-95,730,000USD16,558,000USD
    Change In Working Capital-18,543,000USD-224,465,000USD-36,083,000USD-10,195,000USD
    Total Cash From Operating Activities490,169,000USD-4,653,000USD222,641,000USD76,454,000USD
    Capital Expenditures-95,484,000USD-70,113,000USD-51,908,000USD-33,201,000USD
    Free Cash Flow394,685,000USD-74,766,000USD170,733,000USD43,253,000USD
    Total Cashflows From Investing Activities-305,079,000USD45,356,000USD-452,867,000USD-37,336,000USD
    Net Borrowings-127,120,000USD-68,930,000USD——
    Total Cash From Financing Activities-157,866,000USD-73,810,000USD473,936,000USD-32,208,000USD
    Sale Purchase Of Stock-43,173,000USD0USD-1,124,000USD—
    Issuance Of Capital Stock0USD0USD0USD—
    Change In Cash27,224,000USD-33,107,000USD243,710,000USD6,910,000USD
    Begin Period Cash Flow61,253,000USD46,735,000USD18,295,000USD23,614,000USD
    End Period Cash Flow88,477,000USD13,628,000USD262,005,000USD30,524,000USD
    Other Cashflows From Investing Activities-5,031,000USD2,135,000USD1,052,000USD-1,724,000USD
    Other Cashflows From Financing Activities-12,854,000USD-4,880,000USD-18,107,000USD-2,654,000USD
    Unclassified Operating Cash Flow14,842,000USD-27,962,000USD22,600,000USD-4,947,000USD
    Unclassified Investing Cash Flow-204,564,000USD67,978,000USD50,856,000USD-2,411,000USD
    Unclassified Financing Cash Flow25,281,000USD—493,167,000USD-29,554,000USD
    Investments—45,356,000USD-452,867,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductCommercial Insurance1,112,500,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductMedicaid436,600,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductMedicare A309,800,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductMedicare B30,600,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductMedicare C720,500,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductMedicare D1,149,900,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductPrivate And Other113,200,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentPharmacy Solutions3,407,100,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentProvider Services466,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductCommercial Insurance1,014,300,000USD0001193125-26-199339
    Q1 2026Quarterly · 2026-03-31ProductMedicaid405,700,000USD0001193125-26-199339
    Q1 2026Quarterly · 2026-03-31ProductMedicare A308,900,000USD0001193125-26-199339
    Q1 2026Quarterly · 2026-03-31ProductMedicare B21,800,000USD0001193125-26-199339
    Q1 2026Quarterly · 2026-03-31ProductMedicare C667,000,000USD0001193125-26-199339
    Q1 2026Quarterly · 2026-03-31ProductMedicare D1,074,100,000USD0001193125-26-199339
    Q1 2026Quarterly · 2026-03-31ProductPrivate And Other121,900,000USD0001193125-26-199339
    Q1 2026Quarterly · 2026-03-31SegmentPharmacy Solutions3,171,300,000USD0001193125-26-199339
    Q1 2026Quarterly · 2026-03-31SegmentProvider Services442,400,000USD0001193125-26-199339
    Q4 2025Quarterly · 2025-12-31ProductCommercial Insurance931,700,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductMedicaid401,500,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductMedicare A296,800,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductMedicare B21,300,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductMedicare C680,800,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductMedicare D1,120,100,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductPrivate And Other98,500,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentPharmacy Solutions3,156,500,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentProvider Services394,200,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductCommercial Insurance3,303,300,000USD0001193125-26-079454
    FY 2025Yearly · 2025-12-31ProductMedicaid1,495,200,000USD0001193125-26-079454
    FY 2025Yearly · 2025-12-31ProductMedicare A1,094,300,000USD0001193125-26-079454
    FY 2025Yearly · 2025-12-31ProductMedicare B82,800,000USD0001193125-26-079454
    FY 2025Yearly · 2025-12-31ProductMedicare C2,413,100,000USD0001193125-26-079454
    FY 2025Yearly · 2025-12-31ProductMedicare D4,097,800,000USD0001193125-26-079454
    FY 2025Yearly · 2025-12-31ProductPrivate And Other424,100,000USD0001193125-26-079454
    FY 2025Yearly · 2025-12-31SegmentPharmacy Solutions11,445,800,000USD0001193125-26-079454
    FY 2025Yearly · 2025-12-31SegmentProvider Services1,464,800,000USD0001193125-26-079454
    Q3 2025Quarterly · 2025-09-30ProductCommercial Insurance869,600,000USD0001193125-25-253631
    Q3 2025Quarterly · 2025-09-30ProductMedicaid415,700,000USD0001193125-25-253631
    Q3 2025Quarterly · 2025-09-30ProductMedicare A270,000,000USD0001193125-25-253631
    Q3 2025Quarterly · 2025-09-30ProductMedicare B20,400,000USD0001193125-25-253631
    Q3 2025Quarterly · 2025-09-30ProductMedicare C621,800,000USD0001193125-25-253631
    Q3 2025Quarterly · 2025-09-30ProductMedicare D1,058,400,000USD0001193125-25-253631
    Q3 2025Quarterly · 2025-09-30ProductPrivate And Other78,200,000USD0001193125-25-253631
    Q3 2025Quarterly · 2025-09-30SegmentPharmacy Solutions2,967,000,000USD0001193125-25-253631
    Q3 2025Quarterly · 2025-09-30SegmentProvider Services367,100,000USD0001193125-25-253631
    Q2 2025Quarterly · 2025-06-30ProductCommercial Insurance786,100,000USD0000950170-25-101119
    Q2 2025Quarterly · 2025-06-30ProductMedicaid354,700,000USD0000950170-25-101119
    Q2 2025Quarterly · 2025-06-30ProductMedicare A264,700,000USD0000950170-25-101119
    Q2 2025Quarterly · 2025-06-30ProductMedicare B20,100,000USD0000950170-25-101119
    Q2 2025Quarterly · 2025-06-30ProductMedicare C590,200,000USD0000950170-25-101119
    Q2 2025Quarterly · 2025-06-30ProductMedicare D1,008,400,000USD0000950170-25-101119
    Q2 2025Quarterly · 2025-06-30ProductPrivate And Other123,500,000USD0000950170-25-101119
    Q2 2025Quarterly · 2025-06-30SegmentPharmacy Solutions2,790,100,000USD0000950170-25-101119
    Q2 2025Quarterly · 2025-06-30SegmentProvider Services357,600,000USD0000950170-25-101119
    Q1 2025Quarterly · 2025-03-31ProductCommercial Insurance715,900,000USD0001193125-26-199339
    Q1 2025Quarterly · 2025-03-31ProductMedicaid323,300,000USD0001193125-26-199339
    Q1 2025Quarterly · 2025-03-31ProductMedicare A262,800,000USD0001193125-26-199339
    Q1 2025Quarterly · 2025-03-31ProductMedicare B21,000,000USD0001193125-26-199339
    Q1 2025Quarterly · 2025-03-31ProductMedicare C520,300,000USD0001193125-26-199339
    Q1 2025Quarterly · 2025-03-31ProductMedicare D910,900,000USD0001193125-26-199339
    Q1 2025Quarterly · 2025-03-31ProductPrivate And Other123,900,000USD0001193125-26-199339
    Q1 2025Quarterly · 2025-03-31SegmentPharmacy Solutions2,532,200,000USD0001193125-26-199339
    Q1 2025Quarterly · 2025-03-31SegmentProvider Services345,900,000USD0001193125-26-199339
    Q4 2024Quarterly · 2024-12-31ProductCommercial Insurance709,500,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductMedicaid314,100,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductMedicare A273,300,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductMedicare B26,800,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductMedicare C459,800,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductMedicare D849,500,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductPrivate And Other113,900,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentPharmacy Solutions2,397,100,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentProvider Services349,800,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductCommercial Insurance2,528,100,000USD0001193125-26-079454
    FY 2024Yearly · 2024-12-31ProductMedicaid1,166,500,000USD0001193125-26-079454
    FY 2024Yearly · 2024-12-31ProductMedicare A999,600,000USD0001193125-26-079454
    FY 2024Yearly · 2024-12-31ProductMedicare B95,900,000USD0001193125-26-079454
    FY 2024Yearly · 2024-12-31ProductMedicare C1,665,000,000USD0001193125-26-079454
    FY 2024Yearly · 2024-12-31ProductMedicare D3,202,000,000USD0001193125-26-079454
    FY 2024Yearly · 2024-12-31ProductPrivate And Other415,100,000USD0001193125-26-079454
    FY 2024Yearly · 2024-12-31SegmentPharmacy Solutions8,754,300,000USD0001193125-26-079454
    FY 2024Yearly · 2024-12-31SegmentProvider Services1,317,900,000USD0001193125-26-079454
    Q3 2024Quarterly · 2024-09-30ProductCommercial Insurance661,000,000USD0001193125-25-253631
    Q3 2024Quarterly · 2024-09-30ProductMedicaid298,800,000USD0001193125-25-253631
    Q3 2024Quarterly · 2024-09-30ProductMedicare A256,200,000USD0001193125-25-253631
    Q3 2024Quarterly · 2024-09-30ProductMedicare B20,500,000USD0001193125-25-253631
    Q3 2024Quarterly · 2024-09-30ProductMedicare C442,100,000USD0001193125-25-253631
    Q3 2024Quarterly · 2024-09-30ProductMedicare D826,200,000USD0001193125-25-253631
    Q3 2024Quarterly · 2024-09-30ProductPrivate And Other96,400,000USD0001193125-25-253631
    Q3 2024Quarterly · 2024-09-30SegmentPharmacy Solutions2,265,700,000USD0001193125-25-253631
    Q3 2024Quarterly · 2024-09-30SegmentProvider Services335,500,000USD0001193125-25-253631
    FY 2023Yearly · 2023-12-31ProductCommercial Insurance1,810,200,000USD0001193125-26-079454
    FY 2023Yearly · 2023-12-31ProductMedicaid979,100,000USD0001193125-26-079454
    FY 2023Yearly · 2023-12-31ProductMedicare A958,600,000USD0001193125-26-079454
    FY 2023Yearly · 2023-12-31ProductMedicare B82,800,000USD0001193125-26-079454
    FY 2023Yearly · 2023-12-31ProductMedicare C1,450,400,000USD0001193125-26-079454
    FY 2023Yearly · 2023-12-31ProductMedicare D2,031,900,000USD0001193125-26-079454
    FY 2023Yearly · 2023-12-31ProductPrivate And Other378,000,000USD0001193125-26-079454
    FY 2023Yearly · 2023-12-31SegmentPharmacy Solutions6,522,500,000USD0001193125-26-079454
    FY 2023Yearly · 2023-12-31SegmentProvider Services1,168,500,000USD0001193125-26-079454
    FY 2022Yearly · 2022-12-31ProductCommercial Insurance1,470,600,000USD0000950170-25-034196

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.